Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jose M. Cacicedo

Comment on Sims Et Al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258–264

Diabetes Care

English

Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation Through a Calcium and AMPK Dependent Mechanism

PLoS ONE

Multidisciplinary

2014

English

Related publications

Response to Comment on Sims Et Al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258–264

English

Response to Comment on Trinh Et Al. Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153–e154

English

Comment on Rickels Et Al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270

English

Response to Comment on Laiteerapong Et Al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care 2019;42:XXXX–XXXX

English

Comment on Pilemann-Lyberg Et Al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094

English

Response to Comment on Pilemann-Lyberg Et Al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094

English

Comment on Cho Et Al. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Diabetes Care 2019;42:1675–1683

English

Response to Comment on Law Et Al. Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus. Diabetes Care 2019;42:810–815

English

Comment on Lee Et Al. Diabetes 2015;64:2836–2846. Comment on Roberts Et Al. Diabetes 2015;64:471–484

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jose M. Cacicedo

Comment on Sims Et Al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258–264

Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation Through a Calcium and AMPK Dependent Mechanism

Related publications

Response to Comment on Sims Et Al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258–264

Response to Comment on Trinh Et Al. Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153–e154

Comment on Rickels Et Al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270

Response to Comment on Laiteerapong Et Al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care 2019;42:XXXX–XXXX

Comment on Pilemann-Lyberg Et Al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094

Response to Comment on Pilemann-Lyberg Et Al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088–1094

Comment on Cho Et Al. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Diabetes Care 2019;42:1675–1683

Response to Comment on Law Et Al. Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus. Diabetes Care 2019;42:810–815

Comment on Lee Et Al. Diabetes 2015;64:2836–2846. Comment on Roberts Et Al. Diabetes 2015;64:471–484